New prospective in treatment of Parkinson's disease: Studies on permeation of ropinirole through buccal mucosa

International Journal of Pharmaceutics

Volumn 429, Issue 1-2, 2012, Pages 78-83

  De Caro, V ^a   Giandalia, G ^a   Siragusa, M G ^a   Sutera, F M ^a   Giannola, L I ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b MIUR ^*  (Italy)

Author keywords

Absorption enhancement; Buccal delivery; Parkinson's disease; Porcine buccal mucosa; Ropinirole

Indexed keywords

LIMONENE; PENETRATION ENHANCING AGENT; ROPINIROLE;

ANIMAL TISSUE; ARTICLE; CHEEK MUCOSA; CONTROLLED STUDY; DRUG ABSORPTION; DRUG PENETRATION; ELECTRIC FIELD; EX VIVO STUDY; MEMBRANE TRANSPORT; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; STEADY STATE; SWINE;

ADJUVANTS, PHARMACEUTIC; ADMINISTRATION, BUCCAL; ANIMALS; ANTIPARKINSON AGENTS; CYCLOHEXENES; DRUG DELIVERY SYSTEMS; ELECTRICITY; FEASIBILITY STUDIES; INDOLES; IONTOPHORESIS; MODELS, BIOLOGICAL; MOUTH MUCOSA; PARKINSON DISEASE; PERMEABILITY; SWINE; TERPENES; TIME FACTORS;

EID: 84859599368     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.03.022     Document Type: Article

References (29)

1. J.E. Ahlskog Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease Physiol. Behav. 104 2011 168 172
2. A. Azeem, F.J. Ahmad, R.K. Khar, and S. Talegaonkar Nanocarrier for the transdermal delivery of an antiparkinsonian drug AAPS PharmSciTech. 10 2009 1093 1103
3. A. Azeem, S. Talegaonkar, L.M. Negi, F.J. Ahmad, R.K. Khar, and Z. Iqbal Oil based nanocarrier system for transdermal delivery of ropinirole: a mechanistic, pharmacokinetic and biochemical investigation Int. J. Pharm. 422 2012 436 444
4. G. Campisi, C. Paderni, R. Saccone, O. Di Fede, A. Wolff, and L.I. Giannola Human buccal mucosa as an innovative site of drug delivery Curr. Pharm. Des. 16 2010 641 652
5. M. Contin, and P. Martinelli Pharmacokinetics of levodopa J. Neurol. 257 2010 S253 S261
6. V. De Caro, G. Giandalia, M.G. Siragusa, C. Paderni, G. Campisi, and L.I. Giannola Evaluation of galantamine transbuccal absorption by reconstituted human oral epithelium and porcine tissue as buccal mucosa models: part I Eur. J. Pharm. Biopharm. 70 2008 869 873
7. V.H.M. Deneer, G.B. Drese, P.E.H. Roemele, J.C. Verhoef, L.A. Huen, J.H. Kingma, J.R.B.J. Brouwers, and H.E. Junginger Buccal transport of flecainide and sotalol: effect of a bile salt and ionization state Int. J. Pharm. 241 2002 27 134
8. I. Diaz Del Consuelo, G. Pizzolato, F. Falson, R.H. Guy, and Y. Jacques Evaluation of pig esophageal mucosa as a permeability barrier model for buccal tissue J. Pharm. Sci. 94 2005 2777 2788 (Pubitemid 43265399)
9. J.Y. Gal, Y. Fovet, and M. Adib-Yadzi About a synthetic saliva for in vitro studies Talanta 53 2001 1103 1115 (Pubitemid 32231524)
10. L.I. Giannola, V. De Caro, G. Giandalia, M.G. Siragusa, G. Campisi, and A. Wolff Current status in buccal drug delivery Pharm. Technol. Eur. 20 2008 32 39
11. L.I. Giannola, V. De Caro, G. Giandalia, M.G. Siragusa, C. Tripodo, A.M. Florena, and G. Campisi Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design Eur. J. Pharm. Biopharm. 67 2007 425 433 (Pubitemid 47211903)
12. N. Hassan, A. Ahad, M. Ali, and J. Ali Chemical permeation enhancers for transbuccal drug delivery Expert Opin. Drug Deliv. 7 2010 97 112
13. W. Jiang, S. Kim, X. Zhang, R.A. Lionberger, B.M. Davit, D.P. Conner, and L.X. Yu The role of predictive biopharmaceutical modeling and simulation in drug development and regulatory evaluation Int. J. Pharm. 418 2011 151 160
14. U. Kulkarni, R. Mahalingam, I. Pather, X. Li, and B. Jasti Porcine buccal mucosa as in vitro model: effect of biological and experimental variables J. Pharm. Sci. 99 2010 1265 1277
15. A. Luzardo-Alvarez, M. Begoña Delgado-Charro, and J. Blanco-Mendez Iontophoretic delivery of ropinirole hydrochloride: effect of current density and vehicle formulation Pharm. Res. 18 2001 1714 1720 (Pubitemid 34020427)
16. B. Mudry, P.A. Carrupt, R.H. Guy, and M. Begoña Delgado-Charro Quantitative structure-permeation relationship for iontophoretic transport across the skin J. Control. Release 122 2007 165 172 (Pubitemid 47361407)
17. S. Nanaki, I. Koutsidis, I. Koutri, E. Karavas, and D. Bikiaris Miscibility study of chitosan/2-hydroxyethyl starch blends and evaluation of their effectiveness as drug sustained release hydrogels Carbohydr. Polym. 87 2012 1286 1294
18. M.M. Nashatizadeh, K.E. Lyons, and R. Pahwa A review of ropinirole prolonged release in Parkinson's disease Clin. Interv. Aging 4 2009 179 186
19. J.A. Nicolazzo, B.L. Reed, and B.C. Finnin Buccal penetration enhancers - How do they really work? J. Control. Release 105 2005 1 15 (Pubitemid 40805471)
20. J.A. Nicolazzo, B.L. Reed, and B.C. Finnin Modification of buccal drug delivery following pretreatment with skin penetration enhancers J. Pharm. Sci. 93 2004 2054 2063 (Pubitemid 39045486)
21. M. Onofrj, L. Bonanni, M.V. De Angelis, F. Anzellotti, F. Ciccocioppo, and A. Thomas Long half-life and prolonged-release dopamine receptor agonists: a review of ropinirole prolonged-release studies Parkinsonism Relat. Disord. 15S 2009 S85 S92
22. R. Prasad, V. Koul, S. Anand, and R.K. Khar Effect of DC/mDC iontophoresis and terpenes on transdermal permeation of methotrexate: in vitro study Int. J. Pharm. 333 2007 70 78 (Pubitemid 46283271)
23. S. Punitha, and Y. Girish Polymers in mucoadhesive buccal drug delivery system: a review Int. J. Res. Pharm. Sci. 1 2010 170 186
24. G. Ramesh, V.Y. Vamshi, V. Kishan, and R.Y. Madhusudan Studies on the influence of penetration enhancers on in vitro permeation of carvedilol across rat abdominal skin Curr. Trends Biotechnol. Pharm. 1 2007 62 69
25. H. Reichmann Transdermal delivery of dopamine receptor agonists Parkinsonism Relat. Disord. 15S 2009 S93 S96
26. H. Sohi, A. Ahuja, F.J. Ahmad, and R.K. Khar Critical evaluation of permeation enhancers for oral mucosal drug delivery Drug Dev. Ind. Pharm. 36 2010 254 282
27. C.A. Squier, M.J. Mantz, and P.W. Wertz Effect of menthol on the penetration of tobacco carcinogens and nicotine across porcine oral mucosa ex vivo Nicotine Tob. Res. 12 2010 763 767
28. F. Stocchi The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson's disease Parkinsonism Rel. Disord. 15S3 2009 S68 S71
29. D.J. Thompson, and D. Vearer Steady-state pharmacokinetic properties of a 24 h prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease Clin. Ther. 29 2007 2654 2666